Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents (original) (raw)

  1. Dipòsit Digital de la Universitat de Barcelona
  2. Recerca
  3. Ciències Fisiològiques
  4. Articles publicats en revistes (Ciències Fisiològiques)

Si us plau utilitzeu sempre aquest identificador per citar o enllaçar aquest document:https://hdl.handle.net/2445/176306

Títol: Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
Autor: Garcia-Foncillas, JesúsAndion, EstherGoodman, Steve N.Hidalgo, Oscar F.Vanaclocha, VicenteHerman, J.G.
Matèria: Ús terapèuticTumors cerebralsEnzimologiaADNGenèticaGliomaTherapeutic useBrain tumorsEnzymologyDNAGeneticsGliomas
Data de publicació: 9-nov-2000
Publicat per: Massachusetts Medical Society
Resum: Background: the DNA-repair enzyme O6-methylguanine-DNA methyltransferase (MGMT) inhibits the killing of tumor cells by alkylating agents. MGMT activity is controlled by a promoter; methylation of the promoter silences the gene in cancer, and the cells no longer produce MGMT. We examined gliomas to determine whether methylation of the MGMT promoter is related to the responsiveness of the tumor to alkylating agents. Methods: we analyzed the MGMT promoter in tumor DNA by a methylation-specific polymerase-chain-reaction assay. The gliomas were obtained from patients who had been treated with carmustine (1,3-bis(2-chloroethyl)-1-nitrosourea, or BCNU). The molecular data were correlated with the clinical outcome. Results: the MGMT promoter was methylated in gliomas from 19 of 47 patients (40 percent). This finding was associated with regression of the tumor and prolonged overall and disease-free survival. It was an independent and stronger prognostic factor than age, stage, tumor grade, or performance status. Conclusions: methylation of the MGMT promoter in gliomas is a useful predictor of the responsiveness of the tumors to alkylating agents.
Nota: Reproducció del document publicat a: https://doi.org/10.1056/NEJM200011093431901
És part de: New England Journal of Medicine, 2000, vol. 343, num. 19, p. 1350-1354
URI: https://hdl.handle.net/2445/176306
Recurs relacionat: https://doi.org/10.1056/NEJM200011093431901
ISSN: 0028-4793
Apareix en les col·leccions: Articles publicats en revistes (Ciències Fisiològiques)

Aquest document té tots els drets reservats